Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural Ropivacaine Infusion in Cardiac Surgery
NCT07116343Phase 4Recruiting
- Sponsor
- Saint Petersburg State University
- Start
- Oct 2025
- Primary completion
- Sep 2027
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Saint Petersburg State University. Started Oct 2025; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07116343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116343.